(Q35122166)

6 August 2017

1 reference

title

Immunopathology and the gene therapy of lupus (English)

1 reference

6 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732872

30 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

30 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

30 December 2023

author name string

R. A. Mageed

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732872

30 December 2023

G. J. Prud'homme

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732872

30 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12732872

30 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://www.nature.com/articles/3302016.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12732872

https://www.nature.com/articles/3302016.pdf

30 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

https://www.nature.com/articles/3302016

30 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

30 December 2023

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

10

1 reference

6 August 2017

page(s)

861-874

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Studies regarding a possible function for viruses in the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

A revised estimate of twin concordance in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Complement and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Cytokines and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Genetics of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Role of cyclin kinase inhibitor p21 in systemic autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Mutation of DNASE1 in people with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Lupus, DNase and defective disposal of cellular debris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Delineating the genetic basis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

The genes of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the gamma delta T-cell antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Decreased T cell response to anti-CD2 in systemic lupus erythematosus and reversal by anti-CD28: evidence for impaired T cell-accessory cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Complement receptor 2 in the regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Immunopathogenesis of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Cyclic AMP level of lymphocytes in patients with systemic lupus erythematosus and its relation to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Cytokines and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Cytokine mRNA expression in the B/W mouse model of systemic lupus erythematosus--analyses of strain, gender, and age effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Interleukin 6 promotes murine lupus in NZB/NZW F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr/lpr mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Transforming growth factor-beta in disease: the dark side of tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Anticytokine gene therapy of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Systemic immunological effects of cytokine genes injected into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Modulation of the autoimmune response in lupus mice by oral administration of attenuated Salmonella typhimurium expressing the IL-2 and TGF-beta genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

CTLA4-Ig: a novel immunosuppressive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Intramuscular administration of expression plasmids encoding interferon-gamma receptor/IgG1 or IL-4/IgG1 chimeric proteins protects from autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

An improved plasmid DNA expression vector for direct injection into skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Sex effects in systemic lupus erythematosus: a clue to pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Immune cell signaling defects in lupus: activation, anergy and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Hyperproliferation of BXSB B cells is linked to the Yaa allele

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Impaired T-cell activation in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Autoimmunity in heart disease: mechanisms and genetic susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

B-cell kinase lyn deficiency in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Relationship of interleukin-4 to isotypic distribution of anti-double-stranded DNA antibodies in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Interleukin-10 response abnormalities in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production wi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Interleukin-1-production by monocytes from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

Immunoregulation of SLE-like disease by the IL-1 receptor: disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

CTLA4IgG gene delivery prevents autoantibody production and lupus nephritis in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302016

7 January 2021

The Journal of Rheumatology

32

29

2537

CY Ho

2002

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

The Journal of Rheumatology

30 December 2023

60

18

270

PC Dau

1991

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

The Journal of Rheumatology

30 December 2023

85

18

1621

WB Graninger

1991

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

30 December 2023

104

47

267

Y Richaud-Patin

1995

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302016

30 December 2023

Identifiers

1 reference

6 August 2017

1 reference